CSL earnings preview: why CSL is optimistic about its annual earnings
Over the last six months, CSL has managed to overcome market woes by surpassing set benchmarks. Its share price had jumped over 20% while the ASX 200 was down 2%.
CSL Limited release date:
CSL Ltd is expected to release its earnings report on Wednesday, August 17, 2022.
CSL Limited earnings expectation:
- NPAT: US $2.26 billion
- EPS: 6.938 (-4% YOY)
- DPS: 3.075 (-22% YOY)
CSL Limited earnings key watch:
After three years of an average annual earning of 6.14% compared to the industry average of 9.21%, analysts estimate CSL’s annual growth to increase to 7.49% between 2022 and 2023. The optimism is well earned as CSL sold a record volume of 110 million doses of seasonal influenza vaccines in the northern hemisphere.
With plasma collections now well above pre-covid levels and plasma donor fees reduced, this news bodes well for a healthy margin despite inflation headwinds. Furthermore, the power of the CSL brand has allowed the company to increase the price of its products by near double digits without hurting demand.
In terms of the biotech company’s outlook, CSL tips EPS growth of 17% for FY23 and a total shareholder return of 15% over the next 12 months with plasma collections expected to continuously improve and deliver strong revenue growth.
CSL share price and technical analysis:
Over the last six months, CSL has overcome market woes by surpassing set benchmarks. Its share price had jumped over 20% while the ASX 200 was down 2%.
From a technical viewpoint, the share price for CSL was slightly lower after prices failed to clear the $300 psychological level in July. However, the price is still hovering around the year high level. The recently breached 20-day Simple Moving Average (SMA) may put some pressure on the prices while the. MACD and RSI have fallen back to the avaerage but remain above the 50 midpoints.
A break above the trend line would call for a new attempt of the $300 threshold while a move below $289 would erase all the gain from early July.
CSL Limited daily chart
This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Start trading forex today
Trade the largest and most volatile financial market in the world.
- Spreads start at just 0.6 points on EUR/USD
- Analyse market movements with our essential selection of charts
- Speculate from a range of platforms, including on mobile
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only
